Literature DB >> 10849639

The Wada test with propofol in a patient with epilepsy.

T M Silva1, O J Hernández-Fustes, M L Bueno, A M Varela, S Machado.   

Abstract

The usual drug used in the Wada test is amobarbital, but it is not available in Brazil. Propofol was already used by Bazin et al. in 1998, and in their report the test resulted good in the absence of any adverse effect. We report the use of propofol as the anesthetic for the Wada test. The test was carried out in a 26 years old woman with temporal medial lobe epilepsy refractory to medical treatment. Language functions and memory were tested after injection in both hemispheres by three procedures (Seattle, Montreal and Interview procedures). Propofol showed to be good to carry on the Wada test.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10849639     DOI: 10.1590/s0004-282x2000000200024

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  4 in total

1.  Feasibility of the superselective test with propofol for determining eloquent brain regions in the endovascular treatment of arteriovenous malformations.

Authors:  José A Jordán González; Juan Carlos Llibre Guerra; José A Prince López; Frank Vázquez Luna; Raúl Marino Rodríguez Ramos; José Carlos Ugarte Suárez
Journal:  Interv Neuroradiol       Date:  2013-09-26       Impact factor: 1.610

2.  Provocative test with propofol: experience in patients with cerebral arteriovenous malformations who underwent neuroendovascular procedures.

Authors:  C E Feliciano; R de León-Berra; M S Hernández-Gaitán; H M Torres; O Creagh; R Rodríguez-Mercado
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-05       Impact factor: 3.825

Review 3.  Intracarotid delivery of drugs: the potential and the pitfalls.

Authors:  Shailendra Joshi; Phillip M Meyers; Eugene Ornstein
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

4.  Tolerability of propofol in Wada testing.

Authors:  Faisal A Alsallom; Shobhit Sinha; Fahmi M Alsenani; Fawziah A Bamogaddam; Saeed H Wahass; Aurora B Canillo; Khurram A Siddiqui
Journal:  Neurosciences (Riyadh)       Date:  2014-07       Impact factor: 0.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.